Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of deferasirox for the treatment of iron overload associated with regular blood transfusions in patients with chronic anaemia such as beta-thalassaemia major (beta-TM) and sickle cell disease (SCD). Data sources: Electronic data...

詳細記述

書誌詳細

出版年:	Health Technology Assessment
主要な著者:	C McLeod, N Fleeman, J Kirkham, A Bagust, A Boland, P Chu, R Dickson, Y Dundar, J Greenhalgh, B Modell, A Olujohungbe, P Telfer, T Walley
フォーマット:	論文
言語:	英語
出版事項:	NIHR Journals Library 2009-01-01
主題:	deferasirox iron-overload sickle-cell-disease beta-thalassaemia transfusionalhaemosiderosis iron-chelating-agent
オンライン･アクセス:	https://doi.org/10.3310/hta13010